Home LiteratureArticle Details
PMID: 20129251 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Cancer cell ·Vol. 17 ·No. 1 ·2010-01-19 ·Pages 98-110

Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Cancer Genome Atlas Research Network

Abstract

The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma multiforme (GBM). We describe a robust gene expression-based molecular classification of GBM into Proneural, Neural, Classical, and Mesenchymal subtypes and integrate multidimensional genomic data to establish patterns of somatic mutations and DNA copy number. Aberrations and gene expression of EGFR, NF1, and PDGFRA/IDH1 each define the Classical, Mesenchymal, and Proneural subtypes, respectively. Gene signatures of normal brain cell types show a strong relationship between subtypes and different neural lineages. Additionally, response to aggressive therapy differs by subtype, with the greatest benefit in the Classical subtype and no benefit in the Proneural subtype. We provide a framework that unifies transcriptomic and genomic dimensions for GBM molecular stratification with important implications for future studies.

MeSH Terms
Adult Aged Brain Neoplasms/classification,genetics,pathology DNA Mutational Analysis ErbB Receptors/genetics Factor Analysis, Statistical Gene Dosage Gene Expression Gene Expression Profiling Glioblastoma/classification,genetics,pathology Humans Isocitrate Dehydrogenase/genetics Middle Aged Mutation Neurofibromatosis 1/genetics Oligonucleotide Array Sequence Analysis Prognosis Receptor, Platelet-Derived Growth Factor alpha/genetics
Chemicals
Isocitrate Dehydrogenase IDH1 protein, human EGFR protein, human ErbB Receptors Receptor, Platelet-Derived Growth Factor alpha
Authors & Affiliations
34 authors, click to expand affiliations / ORCID
Verhaak Roel G W
The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.
Hoadley Katherine A
Purdom Elizabeth
Wang Victoria
Qi Yuan
Wilkerson Matthew D
Miller C Ryan
Ding Li
Golub Todd
Mesirov Jill P
Alexe Gabriele
Lawrence Michael
O'Kelly Michael
Tamayo Pablo
Weir Barbara A
Gabriel Stacey
Winckler Wendy
Gupta Supriya
Jakkula Lakshmi
Feiler Heidi S
Hodgson J Graeme
James C David
Sarkaria Jann N
Brennan Cameron
Kahn Ari
Spellman Paul T
Wilson Richard K
Speed Terence P
Gray Joe W
Meyerson Matthew
Getz Gad
Perou Charles M
Hayes D Neil
Cancer Genome Atlas Research Network
References (44)
44 references, click to expand
  1. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
    J Natl Cancer Inst. 1993 May 5;85(9):704-10 PMID: 8478956
  2. Primary and secondary glioblastomas: from concept to clinical diagnosis.
    Neuro Oncol. 1999 Jan;1(1):44-51 PMID: 11550301
  3. Identification of molecular subtypes of glioblastoma by gene expression profiling.
    Oncogene. 2003 Apr 17;22(15):2361-73 PMID: 12700671
  4. matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements.
    Bioinformatics. 2004 Jul 10;20(10):1651-2 PMID: 14988118
  5. Gene expression profiling of gliomas strongly predicts survival.
    Cancer Res. 2004 Sep 15;64(18):6503-10 PMID: 15374961
  6. AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets.
    Bioinformatics. 2007 Sep 15;23(18):2385-90 PMID: 17660211
  7. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
    Science. 2002 May 3;296(5569):920-2 PMID: 11988578
  8. Malignant astrocytic glioma: genetics, biology, and paths to treatment.
    Genes Dev. 2007 Nov 1;21(21):2683-710 PMID: 17974913
  9. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.
    Cancer Res. 2006 Apr 15;66(8):3987-91 PMID: 16618716
  10. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
    Nature. 2008 Oct 23;455(7216):1061-8 PMID: 18772890
  11. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
    Cancer Cell. 2006 Mar;9(3):157-73 PMID: 16530701
  12. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
    Cancer Res. 2004 Oct 1;64(19):7011-21 PMID: 15466194
  13. Epidemiology and etiology of gliomas.
    Acta Neuropathol. 2005 Jan;109(1):93-108 PMID: 15685439
  14. Getting a GR(i)P on oligodendrocyte development.
    Dev Biol. 2004 Jan 1;265(1):33-52 PMID: 14697351
  15. Summaries of Affymetrix GeneChip probe level data.
    Nucleic Acids Res. 2003 Feb 15;31(4):e15 PMID: 12582260
  16. Gene expression profiling identifies molecular subtypes of gliomas.
    Oncogene. 2003 Jul 31;22(31):4918-23 PMID: 12894235
  17. Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin.
    Oncogene. 1992 Apr;7(4):627-33 PMID: 1314366
  18. Distinct transcription profiles of primary and secondary glioblastoma subgroups.
    Cancer Res. 2006 Jan 1;66(1):159-67 PMID: 16397228
  19. MGMT gene silencing and benefit from temozolomide in glioblastoma.
    N Engl J Med. 2005 Mar 10;352(10):997-1003 PMID: 15758010
  20. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.
    J Clin Oncol. 2008 Jun 20;26(18):3015-24 PMID: 18565887
  21. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.
    Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5814-9 PMID: 15827123
  22. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Mol Cancer. 2006 Sep 26;5:39 PMID: 17002787
  23. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.
    Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14344-9 PMID: 16186508
  24. Early genetic changes involved in low-grade astrocytic tumor development.
    Curr Mol Med. 2006 Sep;6(6):645-50 PMID: 17022734
  25. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function.
    J Neurosci. 2008 Jan 2;28(1):264-78 PMID: 18171944
  26. DAVID: Database for Annotation, Visualization, and Integrated Discovery.
    Genome Biol. 2003;4(5):P3 PMID: 12734009
  27. ClaNC: point-and-click software for classifying microarrays to nearest centroids.
    Bioinformatics. 2006 Jan 1;22(1):122-3 PMID: 16269418
  28. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
    PLoS One. 2009 Nov 13;4(11):e7752 PMID: 19915670
  29. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling.
    Neuron. 2006 Jul 20;51(2):187-99 PMID: 16846854
  30. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.
    Neuron. 2007 Feb 15;53(4):503-17 PMID: 17296553
  31. The role of tumor resection in the treatment of glioblastoma multiforme in adults.
    Cancer. 1999 Nov 15;86(10):2117-23 PMID: 10570440
  32. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.
    Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):51-5 PMID: 9422557
  33. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.
    Nature. 2009 Nov 5;462(7269):108-12 PMID: 19847166
  34. Identification of genes periodically expressed in the human cell cycle and their expression in tumors.
    Mol Biol Cell. 2002 Jun;13(6):1977-2000 PMID: 12058064
  35. Epithelial-mesenchymal transitions in tumour progression.
    Nat Rev Cancer. 2002 Jun;2(6):442-54 PMID: 12189386
  36. Circular binary segmentation for the analysis of array-based DNA copy number data.
    Biostatistics. 2004 Oct;5(4):557-72 PMID: 15475419
  37. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Cancer Res. 2003 Apr 1;63(7):1602-7 PMID: 12670911
  38. Neural stem cells and the origin of gliomas.
    N Engl J Med. 2005 Aug 25;353(8):811-22 PMID: 16120861
  39. Significance analysis of microarrays applied to the ionizing radiation response.
    Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21 PMID: 11309499
  40. IDH1 and IDH2 mutations in gliomas.
    N Engl J Med. 2009 Feb 19;360(8):765-73 PMID: 19228619
  41. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Brain Pathol. 1996 Jul;6(3):217-23; discussion 23-4 PMID: 8864278
  42. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.
    Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12 PMID: 18077431
  43. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.
    Neuro Oncol. 2009 Oct;11(5):477-87 PMID: 19139420
  44. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.
    Cancer Cell. 2006 Apr;9(4):287-300 PMID: 16616334
Article Info
Journal
Cancer cell
Abbr.
Cancer Cell
ISSN
1878-3686
Published
2010-01-19
Pages
98-110
Language
English
Region
United States
NLM ID
101130617
PMCID
PMC2818769
Subset
IM
Grants
NCI NIH HHS · P50CA58223 · United States
NCI NIH HHS · CA127716 · United States
NCI NIH HHS · U24CA126561 · United States
NHGRI NIH HHS · U54HG003067 · United States
NCI NIH HHS · P50 CA058223 · United States
NCI NIH HHS · L30 CA104183-01 · United States
NINDS NIH HHS · R01 NS049720 · United States
NCI NIH HHS · U24 CA126561 · United States
NCI NIH HHS · CA097257 · United States
NINDS NIH HHS · NS49720 · United States
NHGRI NIH HHS · U54 HG003067 · United States
NCI NIH HHS · P50 CA108961 · United States
NHGRI NIH HHS · U54HG003273 · United States
NCI NIH HHS · L30 CA104183-02 · United States
NCI NIH HHS · U24CA126551 · United States
NCI NIH HHS · U24CA126543 · United States
NCI NIH HHS · U24CA126554 · United States
NCI NIH HHS · U24CA126544 · United States
NCI NIH HHS · U24 CA126551 · United States
NCI NIH HHS · CA108961 · United States
NCRR NIH HHS · UL1 RR024992 · United States
NHGRI NIH HHS · U54 HG003273 · United States
NHGRI NIH HHS · U54HG003079 · United States
NCI NIH HHS · U24 CA126554 · United States
NCI NIH HHS · P50 CA097257 · United States
NCI NIH HHS · R01 CA127716 · United States
NCI NIH HHS · U24 CA143848 · United States
NCRR NIH HHS · RR023248 · United States
NCI NIH HHS · U24 CA126543 · United States
NCI NIH HHS · U24CA126563 · United States
NCI NIH HHS · U24CA126546 · United States
NHGRI NIH HHS · U54 HG003079 · United States
NCRR NIH HHS · K12 RR023248 · United States
NCI NIH HHS · U24 CA143867 · United States
NCI NIH HHS · L30 CA104183 · United States
NIEHS NIH HHS · F30 ES019449 · United States
NCI NIH HHS · U24 CA126546 · United States
NCI NIH HHS · U24 CA126563 · United States
NCI NIH HHS · U24 CA126544 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]